Literature DB >> 19958311

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

M Veny1, M Esteller, E Ricart, J M Piqué, J Panés, A Salas.   

Abstract

BACKGROUND: Th1 and Th17 cells have been implicated in Crohn's disease (CD) pathophysiology and may play a role in disease persistence. Aim To determine Th1 and Th17 responses in intestine and peripheral blood of early (<32 weeks since initial symptoms) and late (>2 years) CD patients.
METHODS: Cytokine mRNA in intestinal biopsies was determined by RT-PCR. Cytokine concentration in culture was measured by ELISA and cytokine-producing cells were identified by intracellular staining.
RESULTS: The inflamed mucosa showed significantly increased IL-17 mRNA levels compared with non-inflamed areas, both in early and late CD patients. However, only patients with late (n = 12), but not early (n = 9), active disease showed increased IL-17 production, as well as a significantly higher percentage of IL-17(+)CD4(+) cells in blood, compared with controls (n = 12) or patients in remission (n = 13). Moreover, cultured peripheral CD4(+) cells from late active CD patients presented significantly higher percentages of IL-17(+), IL-22(+) and IFN-gamma(+) and a significantly increased production of IL-17 and IL-22, but not IFN-gamma(+).
CONCLUSIONS: Increased IL-17 gene transcription is common to early and late CD mucosa. However, exacerbated Th17 responses in the peripheral blood appear only in late disease. We propose that this population may constitute a mechanism of perpetuating the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19958311     DOI: 10.1111/j.1365-2036.2009.04209.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

Review 1.  Inflammation and gastrointestinal Candida colonization.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2011-07-28       Impact factor: 7.934

2.  Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn's-like murine ileitis.

Authors:  Eóin N McNamee; Joanne C Masterson; Marisol Veny; Colm B Collins; Paul Jedlicka; Fergus R Byrne; Gordon Y Ng; Jesús Rivera-Nieves
Journal:  J Leukoc Biol       Date:  2015-01-30       Impact factor: 4.962

Review 3.  Natural history and long-term clinical course of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

4.  Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease.

Authors:  M Bendix; A Dige; B Deleuran; J F Dahlerup; S P Jørgensen; L E Bartels; L B Husted; T Harsløf; B Langdahl; J Agnholt
Journal:  Clin Exp Immunol       Date:  2015-05-05       Impact factor: 4.330

Review 5.  Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom?

Authors:  Pascal Juillerat; Maude Martinho Grueber; Roseline Ruetsch; Giulia Santi; Marianne Vuillèmoz; Pierre Michetti
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-04-28

Review 6.  Ustekinumab for the treatment of Crohn's disease: can it find its niche?

Authors:  Ebby G Simon; Subrata Ghosh; Marietta Iacucci; Gordon W Moran
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 7.  Exploring the Early Phase of Crohn's Disease.

Authors:  Giorgos Bamias; Fabio Cominelli
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-16       Impact factor: 13.576

Review 8.  Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis.

Authors:  Rebecca Rogier; Marije I Koenders; Shahla Abdollahi-Roodsaz
Journal:  J Immunol Res       Date:  2015-02-23       Impact factor: 4.818

9.  CD39 and CD161 modulate Th17 responses in Crohn's disease.

Authors:  Aiping Bai; Alan Moss; Efi Kokkotou; Anny Usheva; Xiaofeng Sun; Adam Cheifetz; Yi Zheng; Maria Serena Longhi; Wenda Gao; Yan Wu; Simon C Robson
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

10.  A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn's disease.

Authors:  Ji-Young Choi; Chung Hoon Yu; Hee-Yeon Jung; Min Kyu Jung; Yong-Jin Kim; Jang-Hee Cho; Chan-Duck Kim; Yong-Lim Kim; Sun-Hee Park
Journal:  BMC Nephrol       Date:  2012-08-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.